From: Renal sympathetic nerve activity after catheter-based renal denervation
PRE-RDN | POST-RDN | p value | |
---|---|---|---|
Parameters | |||
Blood pressure | |||
Office based systolic (mmHg) | 172.0 [162.0–185.0] | 153.0 [140.0–178.0] | 0.036 |
Office based diastolic (mmHg) | 97 [90.5–112.5] | 90.0 [81.5–100.5] | 0.531 |
ABPM daytime systolic (mmHg) | 166.0 [157.0–179.5] | 165.0 [141.5–186.0] | 0.578 |
ABPM daytime diastolic (mmHg) | 98.0 [87.0–108.0] | 93.0 [83.0–99.5] | 0.409 |
ABPM night time systolic (mmHg) | 151.0 [133.5–158.5] | 145.0 [125.0–165.5] | 0.490 |
ABPM night time diastolic (mmHg) | 84.0 [75.5–90.0] | 80.0 [71.0–91.5] | 0.640 |
ABPM average systolic (mmHg) | 160.0 [150.5–173.0] | 157.0 [138.5–174.0] | 0.602 |
ABPM average diastolic (mmHg) | 93.0 [83.5–100.5] | 92.0 [80.0–94.5] | 0.369 |
Antihypertensive drugs | |||
Number of antihypertensive drugs | 4.6 ± 1.3 | 4.4 ± 1.4 | 0.157 |
3 classes, n (%) | 5 (23.8) | 7 (33.3) | |
4 or more classes, n (%) | 16 (76.2) | 14 (66.7) | |
Kidney function | |||
Creatinine serum (μmol/L) | 94.0 [76.5–107.5] | 89.0[73.5–113.5] | 0.369 |
eGFR (ml/min/1.73 m2) | 60.7[48.5–101.9] | 64.6 [48.0–99.9] | 0.218 |
Proteinuria (g/L/24 h) | 0.10 [0.07–0.20] | 0.11 [0.07–0.26] | 0.722 |
Sodium urine (mmol/24 h) | 161 [102–203] | 128 [90–161] | 0.230 |
(Neuro) endocrine activity | |||
Plasma renin activity (μg/A1/L/h) | 1.70 [0.95–3.20] | 1.0 [0.60–1.68] | 0.409 |
Epinephrine supine, plasma (nmol/L) | 0.12 [0.05–0.23] | 0.10 [0.05–0.17] | 0.780 |
Norepinephrine supine, plasma (nmol/L) | 2.43 [1.32–3.78] | 2.76 [1.49–4.02] | 0.324 |
Epinephrine urine (nmol/24 h) | 27.5 [14.5–33.8] | 26.0 [18.0–38.0] | 0.551 |
Norepinephrine urine (nmol/24 h) | 268.5 [137.5–495.0] | 308.5 [237.5–479.3] | 0.245 |
Metanephrine urine (nmol/24 h) | 0.78 [0.49–1.05] | 0.68 [0.50–1.02] | 0.506 |
Normetanephrine urine (nmol/24 h) | 2.13 [1.73–3.37] | 2.53 [1.74–3.02] | 0.911 |